Summit Therapeutics (SMMT) News Today $28.66 +0.59 (+2.10%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$28.65 -0.01 (-0.03%) As of 08/8/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SMMT Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Traders Buy Large Volume of Summit Therapeutics Call Options (NASDAQ:SMMT)August 8 at 12:21 PM | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Invests $308,000 in Summit Therapeutics PLC (NASDAQ:SMMT)August 4, 2025 | marketbeat.comTD Asset Management Inc Reduces Stock Holdings in Summit Therapeutics PLC (NASDAQ:SMMT)July 31, 2025 | marketbeat.comSummit Therapeutics (SMMT) Projected to Post Earnings on TuesdayJuly 30, 2025 | marketbeat.comSkandinaviska Enskilda Banken AB publ Has $1.28 Million Position in Summit Therapeutics PLC (NASDAQ:SMMT)July 30, 2025 | marketbeat.comTrivest Advisors Ltd Acquires New Position in Summit Therapeutics PLC (NASDAQ:SMMT)July 29, 2025 | marketbeat.comSummit Therapeutics Joins Elite Club Of Stocks With RS Ratings Over 90July 28, 2025 | msn.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMTJuly 27, 2025 | prnewswire.comIvyRock Asset Management HK Ltd Sells 74,759 Shares of Summit Therapeutics PLC (NASDAQ:SMMT)July 26, 2025 | marketbeat.comLegato Capital Management LLC Takes Position in Summit Therapeutics PLC (NASDAQ:SMMT)July 26, 2025 | marketbeat.comSummit Therapeutics PLC (NASDAQ:SMMT) Receives Consensus Rating of "Moderate Buy" from AnalystsJuly 24, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMTJuly 22, 2025 | prnewswire.com3 Healthcare Stocks to Buy Before They Announce Game-Changing Clinical Trial ResultsJuly 22, 2025 | fool.comThis Healthcare Stock's Revolutionary Drug Could Make Early Investors RichJuly 21, 2025 | finance.yahoo.comSargent Investment Group LLC Sells 70,000 Shares of Summit Therapeutics PLC (NASDAQ:SMMT)July 21, 2025 | marketbeat.comKingsview Wealth Management LLC Buys Shares of 46,337 Summit Therapeutics PLC (NASDAQ:SMMT)July 21, 2025 | marketbeat.com3 Monster Stocks in the Making to Buy Right NowJuly 20, 2025 | fool.comPrincipal Financial Group Inc. Has $4.75 Million Stock Holdings in Summit Therapeutics PLC (NASDAQ:SMMT)July 18, 2025 | marketbeat.comSMMT Investors Have Opportunity to Join Summit Therapeutics Inc. Fraud Investigation with the Schall Law FirmJuly 17, 2025 | tmcnet.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMTJuly 17, 2025 | prnewswire.comSummit Therapeutics (NASDAQ:SMMT) Shares Up 9% - Still a Buy?July 16, 2025 | marketbeat.comFlorida Financial Advisors LLC Purchases Shares of 12,945 Summit Therapeutics PLC (NASDAQ:SMMT)July 15, 2025 | marketbeat.comSMMT Investors Have Opportunity to Join Summit Therapeutics Inc. Fraud Investigation with the Schall Law FirmJuly 14, 2025 | businesswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMTJuly 12, 2025 | prnewswire.com12,025 Shares in Summit Therapeutics PLC (NASDAQ:SMMT) Purchased by U.S. Capital Wealth Advisors LLCJuly 12, 2025 | marketbeat.comSummit Therapeutics Inc. (SMMT) Stock Price Today - WSJJuly 10, 2025 | wsj.comSummit Therapeutics (NASDAQ:SMMT) Trading 7.6% Higher - Here's WhyJuly 9, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMTJuly 7, 2025 | prnewswire.comSummit Therapeutics (NASDAQ:SMMT) Shares Gap Down - Here's WhyJuly 7, 2025 | marketbeat.comSummit Therapeutics Inc. (SMMT) - Yahoo FinanceJuly 5, 2025 | finance.yahoo.com2 Soaring Stocks With More Upside Potential to Buy and HoldJuly 4, 2025 | fool.comSummit, AstraZeneca in talks over $15 billion partnership deal, Bloomberg News reportsJuly 3, 2025 | msn.comSummit Therapeutics Shares Climb Amid Rumored $15B Deal Talks with AstraZenecaJuly 3, 2025 | msn.comSummit said to be in talks with Astra to license potential rival for Merck’s KeytrudaJuly 3, 2025 | msn.comWhy Summit Therapeutics Stock Soared 8% Higher TodayJuly 3, 2025 | fool.comSummit Therapeutics (NASDAQ:SMMT) Stock Price Down 4.3% - Should You Sell?July 3, 2025 | marketbeat.comSummit Therapeutics Target of Unusually High Options Trading (NASDAQ:SMMT)July 3, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMTJuly 2, 2025 | prnewswire.comHC Wainwright Reiterates Buy Rating for Summit Therapeutics (NASDAQ:SMMT)July 1, 2025 | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Coverage Initiated by Analysts at UBS GroupJuly 1, 2025 | marketbeat.comSummit Therapeutics PLC (NASDAQ:SMMT) Stock Position Lifted by Sovran Advisors LLCJune 29, 2025 | marketbeat.comLisanti Capital Growth LLC Takes Position in Summit Therapeutics PLC (NASDAQ:SMMT)June 29, 2025 | marketbeat.comWall Street Zen Upgrades Summit Therapeutics (NASDAQ:SMMT) to "Hold"June 29, 2025 | marketbeat.comSummit Therapeutics PLC (NASDAQ:SMMT) Given Consensus Recommendation of "Moderate Buy" by BrokeragesJune 29, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMTJune 27, 2025 | prnewswire.comSummit Therapeutics Breaks Above 200-Day Moving Average - Bullish for SMMT - NasdaqJune 26, 2025 | nasdaq.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMTJune 23, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMTJune 22, 2025 | prnewswire.comWorld Equity Group Inc. Sells 14,062 Shares of Summit Therapeutics PLC (NASDAQ:SMMT)June 22, 2025 | marketbeat.comGAMMA Investing LLC Purchases 15,331 Shares of Summit Therapeutics PLC (NASDAQ:SMMT)June 21, 2025 | marketbeat.com Get Summit Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SMMT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Videos SMMT Media Mentions By Week SMMT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SMMT News Sentiment▼0.850.48▲Average Medical News Sentiment SMMT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SMMT Articles This Week▼38▲SMMT Articles Average Week Get Summit Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SMMT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Merck & Co., Inc. News Today GSK News Today Takeda Pharmaceutical News Today argenex News Today BeOne Medicines News Today BioNTech News Today Insmed News Today Teva Pharmaceutical Industries News Today Genmab A/S News Today Ascendis Pharma A/S News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SMMT) was last updated on 8/11/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Summit Therapeutics PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Summit Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access Sale